Corvus Pharmaceuticals, Inc.

Q4 2018 13F Holders

Symbol
CRVS
CUSIP
221015100
Type
Equity
Class
COM
Num filers
62
Total reported value, excl. options
$92.2M
Manager Report Date Value ($000) Shares Option Type